Acute Pyoderma Gangrenosum Does Not Require Surgical Therapy

Archives of Family Medicine

Volumn 7, Issue 4, 1998, Pages 377-380

  Tay, Yong Kwang ^a   Friednash, Marti ^a   Aeling, John L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; ARTICLE; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; PATHOLOGY; PYODERMA GANGRENOSUM; UNNECESSARY PROCEDURE;

ACUTE DISEASE; ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PYODERMA GANGRENOSUM; UNNECESSARY PROCEDURES;

EID: 0032113221     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.7.4.377     Document Type: Article

References (35)

1. Brunsting LA, Goeckerman WH, O'leary PA. Pyoderma (ecthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syph. 1930;22:655-680.
2. Schwaegerle SM, Bergfeld WF, Senitzer D, Tidrick RT. Pyoderma gangrenosum: a review. J Am Acad Dermatol. 1988;18:559-568.
3. Perry HO. Pyoderma gangrenosum. South Med J. 1969;62:899-908.
4. Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol. 1972;106:901-905.
5. Powell FC, Schroeter AL, Su WPD, Perry HO. Pyoderma gangrenosum: a review of 86 patients. Q J Med. 1985;55:173-186.
6. Graham JA, Hansen KK, Rabinowitz LG, Esterly NB. Pyoderma gangrenosum in infants and children. Pediatr Dermatol. 1994;11:10-17.
7. Ross HJ, Moy LA, Kaplan R, Figlin RA. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer. 1991;68:441-443.
8. Johnson ML, Grimwood RE. Leukocyte colony-stimulating factors: a review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol. 1994;130: 77-81.
9. Zonana-Nacach A, Jimenez-Balderas FJ, Martinez-Osuna P, Mintz G. Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis: report of 2 cases and review of the literature. J Rheumatol. 1994;21:1352-1356.
10. Rand R, Brown G, Bostwick J. Pyoderma gangrenosum and progressive cutaneous ulceration. Ann Plast Surg. 1988;20:280-284.
11. Johnson RB, Lazarus GS. Pulse therapy: therapeutic efficacy in the treatment of pyoderma gangrenosum. Arch Dermatol. 1982;118:76-84.
12. Jennings JL. Pyoderma gangrenosum: successful treatment with intralesional steroids. J Am Acad Dermatol. 1983;9:575-580.
13. Soto LD. Diaminodiphenylsulfone and steroids in the treatment of pyoderma gangrenosum. Int J Dermatol. 1970;9:293-300.
14. Michaelsson G, Molin L, Ohman S, et al. Clofazimine: a new agent for the treatment of pyoderma gangrenosum. Arch Dermatol. 1976;112:344-349.
15. Kaplan B, Trau H. Treatment of pyoderma gangrenosum with clofazimine. Int J Dermatol. 1992;31:591-593.
16. Lynch WS, Bergfeld WF. Pyoderma gangrenosum responsive to minocycline hydrochloride. Cutis. 1978;21:535-538.
17. Richardson JB, Callen JP. Pyoderma gangrenosum treated successfully with potassium iodide. J Am Acad Dermatol. 1993;28:1005-1007.
18. Paolini O, Hebuterne X, Flory P, Charles F, Rampal P. Treatment of pyoderma gangrenosum with colchicine. Lancet. 1995;345:1057-1058.
19. Gupta AK, Shear NH, Sauder DN. Efficacy of human intravenous immune globulin in pyoderma gangrenosum. J Am Acad Dermatol. 1995;32:140-142.
20. Newell LM, Malkinson FD. Pyoderma gangrenosum: response to cyclophosphamide therapy. Arch Dermatol. 1983;119:495-497.
21. Callen JP, Case JD, Sager D. Chlorambucil: an effective corticosteroid-sparing therapy for pyoderma gangrenosum. J Am Acad Dermatol. 1989;21:515-519.
22. Elgart G, Stover P, Larson K, et al. Treatment of pyoderma gangrenosum with cyclosporine: results in seven patients. J Am Acad Dermatol. 1991;24:83-86.
23. Matis WL, Ellis CN, Griffiths CEM, Lazarus GS. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol. 1992;128:1060-1064.
24. Abu-Elmagd K, Jegasothy BV, Ackerman CD, et al. Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc. 1991;23: 3328-3329.
25. Cairns BA, Herbst CA, Sartor BR, Briggaman RA, Koruda MJ. Peristomal pyoderma gangrenosum and inflammatory bowel disease. Arch Surg. 1994;129: 769-772.
26. Keltz M, Lebwohl M, Bishop S. Peristomal pyoderma gangrenosum. J Am Acad Dermatol. 1992;27:360-364.
27. Schoetz DJr, Coller JA, Veidenheimer MC. Pyoderma gangrenosum and Crohn's disease: eight cases and a review of the literature. Dis Colon Rectum. 1983;26: 155-158.
28. DeCock KM, Thorne MG. The treatment of pyoderma gangrenosum with sodium cromoglycolate. Br J Dermatol. 1980;102:231-233.
29. Hurwitz RM, Haseman JH. The evolution of pyoderma gangrenosum: a clinico-pathologic correlation. Am J Dermatopathol. 1993;15:28-33.
30. Tsele E, Yu RCH, Chu AC. Pyoderma gangrenosum: response to topical nitrogen mustard. Clin Exp Dermatol. 1992;17:437-440.
31. Anderson LL, Samlaska CP, Cardone JS, Holtzmuller KC. Treatment of pyoderma gangrenosum with 4% cromolyn. Arch Dermatol. 1994;130:1117-1120.
32. Abu-Elmagd K, Van Thiel DH, Jegasothy BV, et al. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Ann Intern Med. 1993;119:595-598.
33. Thomas CY Jr, Crouch JA, Guastello J. Hyperbaric oxygen therapy for pyoderma gangrenosum. Arch Dermatol. 1974;110:445-446.
34. Wasserteil V, Bruce S, Sessoms SL, Guntupalli KK. Pyoderma gangrenosum treated with hyperbaric oxygen therapy. Int J Dermatol. 1992;31:594-596.
35. Fulbright RK, Wolf JE, Tschen JA. Pyoderma gangrenosum at surgery sites. J Dermatol Surg Oncol. 1985;11:883-886.